Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00581321 · ClinicalTrials.gov registry record · NA

Oral Water Ingestion in Heart Transplant Patients

A NA study of Blood Pressure and Cardiac Transplantation, sponsored by Satish R. Raj.

Active
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT00581321 is a NA study of Blood Pressure and Cardiac Transplantation that is active but no longer recruiting, run by Satish R. Raj. The registered enrollment target is 40 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00581321, a NA study of Blood Pressure and Cardiac Transplantation, is active but no longer recruiting, sponsored by Satish R. Raj.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

In this study the investigators propose to assess the hemodynamic response to the ingestion of 16 fl oz of water. The investigators will test the hypothesis that water ingestion will increase the systemic vascular resistance.

Interventions

  • DIETARY_SUPPLEMENT water

Study Locations (2)

Tennessee

  • Tennessee Valley Health Systems (Nashville VA) - Nashville
  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2006-01
Est. Completion 2029-12
Phase NA

Sponsor

Satish R. Raj

7 total trials

What the Registry Record Tells You About NCT00581321

The ClinicalTrials.gov registry entry for NCT00581321 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower). The listed sponsor is Satish R. Raj, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which water is the first listed.

NCT00581321 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00581321 about?

NCT00581321 is a clinical study titled "Oral Water Ingestion in Heart Transplant Patients". In this study the investigators propose to assess the hemodynamic response to the ingestion of 16 fl oz of water. The investigators will test the hypothesis that water ingestion will increase the systemic vascular resistance.

What is the current status of trial NCT00581321?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2006-01. Estimated completion is 2029-12.

What conditions does trial NCT00581321 study?

This clinical trial studies the following conditions: Blood Pressure, Cardiac Transplantation.

What interventions are being tested in trial NCT00581321?

The interventions under investigation include: water (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00581321?

This trial is sponsored by Satish R. Raj, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00581321 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.